Panzem

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2016
0120032016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
The pathways leading to development of neurodegenerative disease and cancer cell death may overlap. Interestingly, the main… (More)
Is this relevant?
2009
2009
BACKGROUND 2-Methoxyestradiol (Panzem, 2ME2) is an endogenous metabolite of estradiol that destabilizes microtubules and exerts… (More)
Is this relevant?
2009
2009
PURPOSE 2-methoxyestradiol (2ME2; Panzem) is an endogenous, estradiol-17beta metabolite that at pharmacologic doses exerts… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2009
Review
2009
C2and C4-position 17β-estradiol metabolites play an important role in breast carcinogenesis. 2-Hydroxyestradiol and 4… (More)
Is this relevant?
2009
2009
e16116 Background: Panzem NCD (2ME2) is a non-estrogenic derivative of estradiol with antiproliferative and antiangiogenic… (More)
Is this relevant?
2008
2008
Clinical studies using the microtubule-targeting agent 2-methoxyestradiol (2ME2; Panzem) in cancer patients show that treatment… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2006
2006
We evaluated the efficacy of systemic 2-methoxyestradiol (2ME2) in a laser-induced murine model of choroidal neovascularization… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
2-Methoxyestradiol (2ME2), a natural metabolite of estradiol, is a potent antitumor and antiangiogenic agent. In vitro, 2ME2… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?